APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithyroid Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antithyroid Preparations Industry Growth and Trends Forecast to 2032

27 December 2025125 pages

Choose your research edition.

Industry ResearchAntithyroid Preparations Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithyroid Preparations Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Antithyroid Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithyroid Preparations Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithyroid Preparations Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Antithyroid Preparations market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antithyroid Preparations include Taishan Xinning Pharmaceutical Co., Ltd., Shenzhen Zhonglian Pharmaceutical Co., Ltd., Shanghai Xinyi Tianping Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Sanmenxia Sinovi Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Liaoning Kangbo Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd. and Jinghua Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antithyroid Preparations market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antithyroid Preparations market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antithyroid Preparations market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antithyroid Preparations.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antithyroid Preparations market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antithyroid Preparations Market by Company

Taishan Xinning Pharmaceutical Co., Ltd.

Shenzhen Zhonglian Pharmaceutical Co., Ltd.

Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Sanmenxia Sinovi Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Liaoning Kangbo Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jinghua Pharmaceutical Group Co., Ltd.

Jinyao Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Guizhou Shengjitang Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.

Guangdong South China Pharmaceutical Group Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Beijing Yongkang Pharmaceutical Co., Ltd.

Beijing Jialin Pharmaceutical Co., Ltd.

Beijing Beiwei Pharmaceutical Co., Ltd.

Upsher-Smith Laboratories, LLC

Teva

Pfizer

Avet Pharmaceuticals Inc.

Antithyroid Preparations Segment by Type

Propylthiouracil

Methimazole

Antithyroid Preparations Segment by Application

Hospital

Clinic

Other

Antithyroid Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antithyroid Preparations manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antithyroid Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Propylthiouracil Table 2. Major Company of Methimazole Table 3. Global Antithyroid Preparations Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 5. Global Antithyroid Preparations Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antithyroid Preparations Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antithyroid Preparations Sales Market Share in Value by Type (2021-2026) Table 8. Global Antithyroid Preparations Price by Type (2021-2026) & (US$/Unit) Table 9. Global Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 10. Global Antithyroid Preparations Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antithyroid Preparations Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antithyroid Preparations Sales Market Share in Value by Type (2027-2032) Table 13. Global Antithyroid Preparations Price by Type (2027-2032) & (US$/Unit) Table 14. North America Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 15. North America Antithyroid Preparations Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 17. Europe Antithyroid Preparations Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Antithyroid Preparations Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 21. Latin America Antithyroid Preparations Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Antithyroid Preparations Sales by Type (2021-2026) & (US$ Million) Table 24. Antithyroid Preparations Industry Trends Table 25. Antithyroid Preparations Industry Drivers Table 26. Antithyroid Preparations Industry Opportunities and Challenges Table 27. Antithyroid Preparations Industry Restraints Table 28. Global Antithyroid Preparations Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antithyroid Preparations Revenue Market Share by Company (2021-2026) Table 30. Global Antithyroid Preparations Sales by Company (2021-2026) & (K Units) Table 31. Global Antithyroid Preparations Sales Share by Company (2021-2026) Table 32. Global Antithyroid Preparations Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Antithyroid Preparations Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antithyroid Preparations Major Company Production Sites and Headquarters Table 35. Global Antithyroid Preparations Company, Product Type & Application Table 36. Global Antithyroid Preparations Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antithyroid Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antithyroid Preparations Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antithyroid Preparations Sales by Region (2021-2026) & (K Units) Table 41. Global Antithyroid Preparations Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antithyroid Preparations Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antithyroid Preparations Sales Market Share in Value by Region (2021-2026) Table 44. Global Antithyroid Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Antithyroid Preparations Sales by Region (2027-2032) & (K Units) Table 46. Global Antithyroid Preparations Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antithyroid Preparations Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antithyroid Preparations Sales Market Share in Value by Region (2027-2032) Table 49. Global Antithyroid Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Antithyroid Preparations Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 52. Global Antithyroid Preparations Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antithyroid Preparations Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antithyroid Preparations Sales Market Share in Value by Application (2021-2026) Table 55. Global Antithyroid Preparations Price by Application (2021-2026) & (US$/Unit) Table 56. Global Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 57. Global Antithyroid Preparations Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antithyroid Preparations Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antithyroid Preparations Sales Market Share in Value by Application (2027-2032) Table 60. Global Antithyroid Preparations Price by Application (2027-2032) & (US$/Unit) Table 61. North America Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 62. North America Antithyroid Preparations Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 64. Europe Antithyroid Preparations Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Antithyroid Preparations Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 68. Latin America Antithyroid Preparations Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Antithyroid Preparations Sales by Application (2021-2026) & (US$ Million) Table 71. Taishan Xinning Pharmaceutical Co., Ltd. Company Information Table 72. Taishan Xinning Pharmaceutical Co., Ltd. Business Overview Table 73. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 75. Taishan Xinning Pharmaceutical Co., Ltd. Recent Development Table 76. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information Table 77. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 78. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 80. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Development Table 81. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information Table 82. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview Table 83. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 85. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Development Table 86. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 87. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 88. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 90. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development Table 91. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information Table 92. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview Table 93. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 95. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Development Table 96. Qilu Pharmaceutical Co., Ltd. Company Information Table 97. Qilu Pharmaceutical Co., Ltd. Business Overview Table 98. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 100. Qilu Pharmaceutical Co., Ltd. Recent Development Table 101. Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information Table 102. Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview Table 103. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 105. Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Development Table 106. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 107. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 108. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 110. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 111. Jinghua Pharmaceutical Group Co., Ltd. Company Information Table 112. Jinghua Pharmaceutical Group Co., Ltd. Business Overview Table 113. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 115. Jinghua Pharmaceutical Group Co., Ltd. Recent Development Table 116. Jinyao Pharmaceutical Co., Ltd. Company Information Table 117. Jinyao Pharmaceutical Co., Ltd. Business Overview Table 118. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 120. Jinyao Pharmaceutical Co., Ltd. Recent Development Table 121. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 122. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 123. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 125. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Development Table 126. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 127. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 128. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 130. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 131. Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information Table 132. Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview Table 133. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 135. Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Development Table 136. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 137. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 138. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 140. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Development Table 141. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information Table 142. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview Table 143. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 145. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Development Table 146. Guangdong South China Pharmaceutical Group Co., Ltd. Company Information Table 147. Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview Table 148. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 150. Guangdong South China Pharmaceutical Group Co., Ltd. Recent Development Table 151. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 152. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 153. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 155. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 156. Beijing Yongkang Pharmaceutical Co., Ltd. Company Information Table 157. Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview Table 158. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 160. Beijing Yongkang Pharmaceutical Co., Ltd. Recent Development Table 161. Beijing Jialin Pharmaceutical Co., Ltd. Company Information Table 162. Beijing Jialin Pharmaceutical Co., Ltd. Business Overview Table 163. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 165. Beijing Jialin Pharmaceutical Co., Ltd. Recent Development Table 166. Beijing Beiwei Pharmaceutical Co., Ltd. Company Information Table 167. Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview Table 168. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 170. Beijing Beiwei Pharmaceutical Co., Ltd. Recent Development Table 171. Upsher-Smith Laboratories, LLC Company Information Table 172. Upsher-Smith Laboratories, LLC Business Overview Table 173. Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio Table 175. Upsher-Smith Laboratories, LLC Recent Development Table 176. Teva Company Information Table 177. Teva Business Overview Table 178. Teva Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Teva Antithyroid Preparations Product Portfolio Table 180. Teva Recent Development Table 181. Pfizer Company Information Table 182. Pfizer Business Overview Table 183. Pfizer Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Pfizer Antithyroid Preparations Product Portfolio Table 185. Pfizer Recent Development Table 186. Avet Pharmaceuticals Inc. Company Information Table 187. Avet Pharmaceuticals Inc. Business Overview Table 188. Avet Pharmaceuticals Inc. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio Table 190. Avet Pharmaceuticals Inc. Recent Development Table 191. North America Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. North America Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 193. North America Antithyroid Preparations Sales Market Share by Country (2021-2026) Table 194. North America Antithyroid Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 195. North America Antithyroid Preparations Sales Market Share Forecast by Country (2027-2032) Table 196. North America Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. North America Antithyroid Preparations Market Size by Country (2021-2026) & (US$ Million) Table 198. North America Antithyroid Preparations Market Share by Country (2021-2026) Table 199. North America Antithyroid Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. North America Antithyroid Preparations Market Share Forecast by Country (2027-2032) Table 201. Europe Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Europe Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 203. Europe Antithyroid Preparations Sales Market Share by Country (2021-2026) Table 204. Europe Antithyroid Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 205. Europe Antithyroid Preparations Sales Market Share Forecast by Country (2027-2032) Table 206. Europe Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Europe Antithyroid Preparations Market Size by Country (2021-2026) & (US$ Million) Table 208. Europe Antithyroid Preparations Market Share by Country (2021-2026) Table 209. Europe Antithyroid Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Europe Antithyroid Preparations Market Share Forecast by Country (2027-2032) Table 211. Asia-Pacific Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Asia-Pacific Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 213. Asia-Pacific Antithyroid Preparations Sales Market Share by Country (2021-2026) Table 214. Asia-Pacific Antithyroid Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 215. Asia-Pacific Antithyroid Preparations Sales Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific Antithyroid Preparations Market Size by Country (2021-2026) & (US$ Million) Table 218. Asia-Pacific Antithyroid Preparations Market Share by Country (2021-2026) Table 219. Asia-Pacific Antithyroid Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Asia-Pacific Antithyroid Preparations Market Share Forecast by Country (2027-2032) Table 221. Latin America Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 222. Latin America Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 223. Latin America Antithyroid Preparations Sales Market Share by Country (2021-2026) Table 224. Latin America Antithyroid Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 225. Latin America Antithyroid Preparations Sales Market Share Forecast by Country (2027-2032) Table 226. Latin America Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Latin America Antithyroid Preparations Market Size by Country (2021-2026) & (US$ Million) Table 228. Latin America Antithyroid Preparations Market Share by Country (2021-2026) Table 229. Latin America Antithyroid Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Latin America Antithyroid Preparations Market Share Forecast by Country (2027-2032) Table 231. Middle East and Africa Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 232. Middle East and Africa Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 233. Middle East and Africa Antithyroid Preparations Sales Market Share by Country (2021-2026) Table 234. Middle East and Africa Antithyroid Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 235. Middle East and Africa Antithyroid Preparations Sales Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa Antithyroid Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa Antithyroid Preparations Market Size by Country (2021-2026) & (US$ Million) Table 238. Middle East and Africa Antithyroid Preparations Market Share by Country (2021-2026) Table 239. Middle East and Africa Antithyroid Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Middle East and Africa Antithyroid Preparations Market Share Forecast by Country (2027-2032) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Antithyroid Preparations Distributors List Table 244. Antithyroid Preparations Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Antithyroid Preparations Image Figure 2. Global Antithyroid Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithyroid Preparations Market Size (2021-2032) & (US$ Million) Figure 4. Global Antithyroid Preparations Sales (2021-2032) & (K Units) Figure 5. Propylthiouracil Image Figure 6. Global Propylthiouracil Sales YoY Growth (2021-2032) & (K Units) Figure 7. Methimazole Image Figure 8. Global Methimazole Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Antithyroid Preparations Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antithyroid Preparations Market Share by Type 2025 VS 2032 Figure 11. North America Antithyroid Preparations Sales Market Share in Volume by Type in 2025 Figure 12. North America Antithyroid Preparations Sales Market Share in Value by Type in 2025 Figure 13. Europe Antithyroid Preparations Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antithyroid Preparations Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antithyroid Preparations Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antithyroid Preparations Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antithyroid Preparations Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antithyroid Preparations Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antithyroid Preparations Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antithyroid Preparations Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antithyroid Preparations Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Antithyroid Preparations Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antithyroid Preparations Market Share by Application 2025 VS 2032 Figure 31. North America Antithyroid Preparations Sales Market Share in Volume by Application in 2025 Figure 32. North America Antithyroid Preparations Sales Market Share in Value by Application in 2025 Figure 33. Europe Antithyroid Preparations Sales Market Share in Volume by Application in 2025 Figure 34. Europe Antithyroid Preparations Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Antithyroid Preparations Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Antithyroid Preparations Sales Market Share in Value by Application in 2025 Figure 37. Latin America Antithyroid Preparations Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Antithyroid Preparations Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Antithyroid Preparations Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Antithyroid Preparations Sales Market Share in Value by Application in 2025 Figure 41. North America Antithyroid Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Antithyroid Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Antithyroid Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antithyroid Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Antithyroid Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Antithyroid Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antithyroid Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Antithyroid Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Antithyroid Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antithyroid Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Antithyroid Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Antithyroid Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antithyroid Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Antithyroid Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Antithyroid Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Antithyroid Preparations Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Antithyroid Preparations Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Propylthiouracil
  • Methimazole
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Taishan Xinning Pharmaceutical Co., Ltd.
  • Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  • Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Liaoning Kangbo Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jinghua Pharmaceutical Group Co., Ltd.
  • Jinyao Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Guizhou Shengjitang Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  • Guangdong South China Pharmaceutical Group Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Beijing Yongkang Pharmaceutical Co., Ltd.
  • Beijing Jialin Pharmaceutical Co., Ltd.
  • Beijing Beiwei Pharmaceutical Co., Ltd.
  • Upsher-Smith Laboratories, LLC
  • Teva
  • Pfizer
  • Avet Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antithyroid Preparations Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antithyroid Preparations Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antithyroid Preparations Market by Type
  6. 1.3.1 Propylthiouracil
  7. 1.3.2 Methimazole
  8. 1.4 Global Antithyroid Preparations Market Size by Type
  9. 1.4.1 Global Antithyroid Preparations Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antithyroid Preparations Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antithyroid Preparations Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antithyroid Preparations Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antithyroid Preparations Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antithyroid Preparations Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antithyroid Preparations Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antithyroid Preparations Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antithyroid Preparations Industry Trends
  2. 2.2 Antithyroid Preparations Industry Drivers
  3. 2.3 Antithyroid Preparations Industry Opportunities and Challenges
  4. 2.4 Antithyroid Preparations Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antithyroid Preparations Revenue (2021-2026)
  2. 3.2 Global Top Players by Antithyroid Preparations Sales (2021-2026)
  3. 3.3 Global Top Players by Antithyroid Preparations Price (2021-2026)
  4. 3.4 Global Antithyroid Preparations Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antithyroid Preparations Major Company Production Sites & Headquarters
  6. 3.6 Global Antithyroid Preparations Company, Product Type & Application
  7. 3.7 Global Antithyroid Preparations Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antithyroid Preparations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antithyroid Preparations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antithyroid Preparations Tier 1, Tier 2, and Tier 3
4 Antithyroid Preparations Regional Status and Outlook
  1. 4.1 Global Antithyroid Preparations Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antithyroid Preparations Historic Market Size by Region
  3. 4.2.1 Global Antithyroid Preparations Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antithyroid Preparations Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antithyroid Preparations Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antithyroid Preparations Forecasted Market Size by Region
  7. 4.3.1 Global Antithyroid Preparations Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antithyroid Preparations Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antithyroid Preparations Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antithyroid Preparations by Application
  1. 5.1 Antithyroid Preparations Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Antithyroid Preparations Market Size by Application
  6. 5.2.1 Global Antithyroid Preparations Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antithyroid Preparations Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antithyroid Preparations Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antithyroid Preparations Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antithyroid Preparations Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antithyroid Preparations Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antithyroid Preparations Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antithyroid Preparations Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Taishan Xinning Pharmaceutical Co., Ltd.
  2. 6.1.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  6. 6.1.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  8. 6.2.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  12. 6.2.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  14. 6.3.1 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  18. 6.3.5 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  20. 6.4.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  24. 6.4.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  26. 6.5.1 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  30. 6.5.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Qilu Pharmaceutical Co., Ltd.
  32. 6.6.1 Qilu Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  36. 6.6.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Liaoning Kangbo Pharmaceutical Co., Ltd.
  38. 6.7.1 Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  42. 6.7.5 Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Liaoning Dongyi Pharmaceutical Co., Ltd.
  44. 6.8.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  48. 6.8.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jinghua Pharmaceutical Group Co., Ltd.
  50. 6.9.1 Jinghua Pharmaceutical Group Co., Ltd. Company Information
  51. 6.9.2 Jinghua Pharmaceutical Group Co., Ltd. Business Overview
  52. 6.9.3 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  54. 6.9.5 Jinghua Pharmaceutical Group Co., Ltd. Recent Developments
  55. 6.10 Jinyao Pharmaceutical Co., Ltd.
  56. 6.10.1 Jinyao Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Jinyao Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  60. 6.10.5 Jinyao Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  62. 6.11.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  66. 6.11.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Hunan Hansen Pharmaceutical Co., Ltd.
  68. 6.12.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  72. 6.12.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Guizhou Shengjitang Pharmaceutical Co., Ltd.
  74. 6.13.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  78. 6.13.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  80. 6.14.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  84. 6.14.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  86. 6.15.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
  87. 6.15.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
  88. 6.15.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  90. 6.15.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
  91. 6.16 Guangdong South China Pharmaceutical Group Co., Ltd.
  92. 6.16.1 Guangdong South China Pharmaceutical Group Co., Ltd. Company Information
  93. 6.16.2 Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview
  94. 6.16.3 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  96. 6.16.5 Guangdong South China Pharmaceutical Group Co., Ltd. Recent Developments
  97. 6.17 Beijing Taiyang Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  102. 6.17.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Beijing Yongkang Pharmaceutical Co., Ltd.
  104. 6.18.1 Beijing Yongkang Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  108. 6.18.5 Beijing Yongkang Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Beijing Jialin Pharmaceutical Co., Ltd.
  110. 6.19.1 Beijing Jialin Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Beijing Jialin Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  114. 6.19.5 Beijing Jialin Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Beijing Beiwei Pharmaceutical Co., Ltd.
  116. 6.20.1 Beijing Beiwei Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  120. 6.20.5 Beijing Beiwei Pharmaceutical Co., Ltd. Recent Developments
  121. 6.21 Upsher-Smith Laboratories, LLC
  122. 6.21.1 Upsher-Smith Laboratories, LLC Company Information
  123. 6.21.2 Upsher-Smith Laboratories, LLC Business Overview
  124. 6.21.3 Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio
  126. 6.21.5 Upsher-Smith Laboratories, LLC Recent Developments
  127. 6.22 Teva
  128. 6.22.1 Teva Company Information
  129. 6.22.2 Teva Business Overview
  130. 6.22.3 Teva Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Teva Antithyroid Preparations Product Portfolio
  132. 6.22.5 Teva Recent Developments
  133. 6.23 Pfizer
  134. 6.23.1 Pfizer Company Information
  135. 6.23.2 Pfizer Business Overview
  136. 6.23.3 Pfizer Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Pfizer Antithyroid Preparations Product Portfolio
  138. 6.23.5 Pfizer Recent Developments
  139. 6.24 Avet Pharmaceuticals Inc.
  140. 6.24.1 Avet Pharmaceuticals Inc. Company Information
  141. 6.24.2 Avet Pharmaceuticals Inc. Business Overview
  142. 6.24.3 Avet Pharmaceuticals Inc. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio
  144. 6.24.5 Avet Pharmaceuticals Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Antithyroid Preparations Sales by Country
  2. 7.1.1 North America Antithyroid Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antithyroid Preparations Sales by Country (2021-2026)
  4. 7.1.3 North America Antithyroid Preparations Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antithyroid Preparations Market Size by Country
  6. 7.2.1 North America Antithyroid Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antithyroid Preparations Market Size by Country (2021-2026)
  8. 7.2.3 North America Antithyroid Preparations Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antithyroid Preparations Sales by Country
  2. 8.1.1 Europe Antithyroid Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antithyroid Preparations Sales by Country (2021-2026)
  4. 8.1.3 Europe Antithyroid Preparations Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antithyroid Preparations Market Size by Country
  6. 8.2.1 Europe Antithyroid Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antithyroid Preparations Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antithyroid Preparations Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antithyroid Preparations Sales by Country
  2. 9.1.1 Asia-Pacific Antithyroid Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antithyroid Preparations Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antithyroid Preparations Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antithyroid Preparations Market Size by Country
  6. 9.2.1 Asia-Pacific Antithyroid Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antithyroid Preparations Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antithyroid Preparations Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antithyroid Preparations Sales by Country
  2. 10.1.1 South America Antithyroid Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antithyroid Preparations Sales by Country (2021-2026)
  4. 10.1.3 South America Antithyroid Preparations Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antithyroid Preparations Market Size by Country
  6. 10.2.1 South America Antithyroid Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antithyroid Preparations Market Size by Country (2021-2026)
  8. 10.2.3 South America Antithyroid Preparations Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antithyroid Preparations Sales by Country
  2. 11.1.1 Middle East and Africa Antithyroid Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antithyroid Preparations Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antithyroid Preparations Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antithyroid Preparations Market Size by Country
  6. 11.2.1 Middle East and Africa Antithyroid Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antithyroid Preparations Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antithyroid Preparations Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antithyroid Preparations Value Chain Analysis
  2. 12.1.1 Antithyroid Preparations Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antithyroid Preparations Production Mode & Process
  7. 12.2 Antithyroid Preparations Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antithyroid Preparations Distributors
  10. 12.2.3 Antithyroid Preparations Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst